Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-047854

Director sold 30,000 shares at an average $59.96 ($1,798,800)

  • Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WINGER DENNIS L Director 2018-08-17 Option exercise +15,000 $14.26 $213,900 57,750 D: show line 1 in the form
WINGER DENNIS L Director 2018-08-17 Sale −15,000 $59.62 $894,300 42,750 D: show line 2 in the form
WINGER DENNIS L Director 2018-08-21 Option exercise +15,000 $14.26 $213,900 57,750 D: show line 3 in the form
WINGER DENNIS L Director 2018-08-21 Sale −15,000 $60.30 $904,500 42,750 D: show line 4 in the form
Open-market sales · 30,000 sh · avg $59.96 · $1,798,800

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WINGER DENNIS L Director 2018-08-17 Option exercise · Stock Option −15,000 $14.26 $213,900 15,000 D: show line 5 in the form
WINGER DENNIS L Director 2018-08-21 Option exercise · Stock Option −15,000 $14.26 $213,900 0 D: show line 6 in the form
Loading xslF345X03/doc4.xml…